Gene Alterations in Paired Supernatants and Precipitates from Malignant Pleural Effusions of Non-Squamous Non-Small Cell Lung Cancer
Li, Jianqiang4,5,6; Li, Xingliang2,7; Wang, Wenxian3,4,5; Shao, Yang1; Zhang, Yiping3,4,5; Song, Zhengbo3,4,5
刊名TRANSLATIONAL ONCOLOGY
2020-08-01
卷号13
ISSN号1936-5233
DOI10.1016/j.tranon.2020.100784
通讯作者Song, Zhengbo(songzb@zjcc.org.cn)
英文摘要OBJECTIVE: This study investigated the feasibility of using malignant pleural effusion (MPE) supernatant and paired cell blocks (precipitate) for gene profiling in patients with non-small cell lung cancer (NSCLC) using next-generation sequencing (NGS) technique. METHODS: Stage IV non-squamous NSCLC patients with MPE were eligible in this prospective study and recruited from Zhejiang Cancer Hospital between May 2014 and October 2015. MPE supernatant and paired precipitate sample gene alterations were determined with NGS containing 14 cancer-related genes. Progression free survival (PFS) was evaluated using Kaplan-Meier method and compared using log-rank test. RESULTS: A total of 102 patients were enrolled in the present study. All pleural effusions were confirmed as malignant with cytological smears. A total of 77 paired MPE supernatant and precipitate samples were acquired from the 102 patients. The results revealed that there were no statistically significant differences in the detection rate and maximum allelic fraction between supernatant and precipitate samples (P = 1.0 and P = .6). Collectively, 172 and 158 genomic alterations with 112 shared mutations were identified in supernatant and precipitate samples, respectively. Comparable PFS was found in FGFR mutation patients according to the supernatant and precipitate sample results (14.0 vs.13.9 months, P = .90). CONCLUSIONS: These results demonstrated that MPE supernatants were comparable to precipitate samples for detection of genetic alteration. However, gene mutation heterogeneity was found between these two media types.
资助项目National Natural Science Foundation of China[81802276]
WOS关键词LIQUID BIOPSY ; EGFR MUTATION ; FREE DNA ; CRIZOTINIB ; TISSUE ; NSCLC ; ALK
WOS研究方向Oncology
语种英语
出版者ELSEVIER SCIENCE INC
WOS记录号WOS:000544673300003
资助机构National Natural Science Foundation of China
内容类型期刊论文
源URL[http://ir.hfcas.ac.cn:8080/handle/334002/94808]  
专题中国科学院合肥物质科学研究院
通讯作者Song, Zhengbo
作者单位1.Geneseeq Technol Inc, Translat Med Res Ctr, Toronto, ON, Canada
2.Zhejiang Rongjun Hosp, Treatment Ctr, Jiaxing 314000, Zhejiang, Peoples R China
3.Zhejiang Canc Hosp, Dept Med Oncol, Hangzhou 301122, Zhejiang, Peoples R China
4.Chinese Acad Sci, Inst Canc & Basic Med, Hangzhou 310022, Peoples R China
5.Univ Chinese Acad Sci, Dept Thorac Oncol Surg, Canc Hosp, Hangzhou 310022, Peoples R China
6.Zhejiang Canc Hosp, Dept Thorac Oncol Surg, Hangzhou 310022, Peoples R China
7.Zhejiang Rongjun Hosp, Dept Thorac Dis Diag, Jiaxing 314000, Zhejiang, Peoples R China
推荐引用方式
GB/T 7714
Li, Jianqiang,Li, Xingliang,Wang, Wenxian,et al. Gene Alterations in Paired Supernatants and Precipitates from Malignant Pleural Effusions of Non-Squamous Non-Small Cell Lung Cancer[J]. TRANSLATIONAL ONCOLOGY,2020,13.
APA Li, Jianqiang,Li, Xingliang,Wang, Wenxian,Shao, Yang,Zhang, Yiping,&Song, Zhengbo.(2020).Gene Alterations in Paired Supernatants and Precipitates from Malignant Pleural Effusions of Non-Squamous Non-Small Cell Lung Cancer.TRANSLATIONAL ONCOLOGY,13.
MLA Li, Jianqiang,et al."Gene Alterations in Paired Supernatants and Precipitates from Malignant Pleural Effusions of Non-Squamous Non-Small Cell Lung Cancer".TRANSLATIONAL ONCOLOGY 13(2020).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace